Your browser doesn't support javascript.
loading
Predicting reactivity threshold in children with anaphylaxis to peanut.
Reier-Nilsen, T; Michelsen, M M; Lødrup Carlsen, K C; Carlsen, K-H; Mowinckel, P; Nygaard, U C; Namork, E; Borres, M P; Håland, G.
Afiliação
  • Reier-Nilsen T; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Michelsen MM; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Lødrup Carlsen KC; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Carlsen KH; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Mowinckel P; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Nygaard UC; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Namork E; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Borres MP; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Håland G; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Clin Exp Allergy ; 48(4): 415-423, 2018 04.
Article em En | MEDLINE | ID: mdl-29284183
ABSTRACT

BACKGROUND:

Peanut allergy necessitates dietary restrictions, preferably individualized by determining reactivity threshold through an oral food challenge (OFC). However, risk of systemic reactions often precludes OFC in children with severe peanut allergy.

OBJECTIVE:

We aimed to determine whether clinical and/or immunological characteristics were associated with reactivity threshold in children with anaphylaxis to peanut and secondarily, to investigate whether these characteristics were associated with severity of the allergic reaction during OFC.

METHODS:

A double-blinded placebo-controlled food challenge (DBPCFC) with peanut was performed in 96 5- to 15-year-old children with a history of severe allergic reactions to peanut and/or sensitization to peanut (skin prick test [SPT] ≥3 mm or specific immunoglobulin E [s-IgE] ≥0.35 kUA/L). Investigations preceding the DBPCFC included a structured interview, SPT, lung function measurements, serological immunology assessment (IgE, IgG and IgG4 ), basophil activation test (BAT) and conjunctival allergen provocation test (CAPT). International standards were used to define anaphylaxis and grade the allergic reaction during OFC.

RESULTS:

During DBPCFC, all 96 children (median age 9.3, range 5.1-15.2) reacted with anaphylaxis (moderate objective symptoms from at least two organ systems). Basophil activation (CD63+ basophils ≥15%), peanut SPT and the ratio of peanut s-IgE/total IgE were significantly associated with reactivity threshold and lowest observed adverse events level (LOAEL) (all P < .04). Basophil activation best predicted very low threshold level (<3 mg of peanut protein), with an optimal cut-off of 75.8% giving a 93.5% negative predictive value. None of the characteristics were significantly associated with the severity of allergic reaction. CONCLUSION AND CLINICAL RELEVANCE In children with anaphylaxis to peanut, basophil activation, peanut SPT and the ratio of peanut s-IgE/total IgE were associated with reactivity threshold and LOAEL, but not with allergy reaction severity.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alérgenos / Técnicas Imunológicas / Hipersensibilidade a Amendoim Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alérgenos / Técnicas Imunológicas / Hipersensibilidade a Amendoim Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article